North America Inhalable Drugs Market Size, Share, Analysis, Industry Report and Forecast 2020-2026
The North American inhalable drug market is anticipated to grow at a CAGR of 2.8% over the forecast period (2020-2026). The key factors that drive the growth of the inhalable drugs industry is the rising prevalence of various respiratory and non- respiratory diseases that create the demand for inhalable drugs. Further, the increasing geriatric population who find it difficult in swallowing a drug created the demand for inhalable drugs and hence drives the market growth
To Request a Sample of our Report on North America
Inhalable Drugs Market: https://www.omrglobal.com/request-sample/north-american-inhalable-drugs-market
North America has a well-developed healthcare
infrastructure, owing to which, the companies invest largely in the development
of innovative solutions including inhalable drugs. The inclination of the people
towards the sedentary lifestyle along with unhealthy eating habits such as a
large number of smokers is a prime factor for the increasing prevalence of
several respiratory diseases such as COPD and asthma. North America region is
also an early adopter of advanced technology assuring substantial market
growth.
Amongst the US and Canada in the region, the US
market in North America is estimated to be a dominating region over the
forecast period. Besides, the presence of several key players such as Johnson
& Johnson Services Inc., and Merck & Co., Inc., Pfizer Inc., and Bausch
Health Companies Inc., are also contributing to the growth of the inhalable
drugs industry in North America. Thus, such aforementioned factors are likely
to create a wide scope for the growth of the market in the region over the
forecast period.
Market Coverage
·
Market number available for – 2019-2026
·
Base year- 2019
·
Forecast period- 2020-2026
·
Segment Covered- By Application and By Route of
Administration
·
Regions Covered- North America
·
Competitive Landscape- Pfizer Inc., Novartis
International AG, GlaxoSmithKline Plc, Johnson & Johnson Services Inc.,
Bausch Health Companies Inc., and TFF Pharmaceuticals, Inc.
(Get 15% Discount on Buying this Report)
A
full Report of North America Inhalable Drugs Market is Available
at: https://www.omrglobal.com/industry-reports/north-american-inhalable-drugs-market
North America Inhalable Drugs Market – Segmentation
By Application
·
Respiratory Diseases
·
Non- Respiratory Diseases
By Route of Administration
·
Nasal
·
Mouth
North America Inhalable Drugs Market – Countries Covered
·
US
·
Canada
Competitive Landscape
·
AstraZeneca Plc
·
Overview
·
AstraZeneca Plc in North America
·
AstraZeneca Plc in Inhalable Drugs Industry
·
Recent Developments
·
AptarGroup, Inc.
·
Bausch Health Companies Inc.
·
Boehringer Ingelheim International GmbH
·
Cipla Ltd.
·
GlaxoSmithKline Plc
·
Johnson & Johnson Services Inc.
·
Merck & Co., Inc.
·
Novartis International AG
·
Pfizer Inc.
·
Sanofi SA
·
TFF Pharmaceuticals, Inc.
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/north-american-inhalable-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated research
reports, customized research reports, consulting and other research-based
services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment